Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,027,744
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
13,265,273
-
Shares change
-
-124,742
-
Total reported value, excl. options
-
$19,631,094
-
Value change
-
-$159,489
-
Number of buys
-
11
-
Number of sells
-
-18
-
Price
-
$1.48
Significant Holders of NextCure, Inc. - Common Stock (NXTC) as of Q1 2023
50 filings reported holding NXTC - NextCure, Inc. - Common Stock as of Q1 2023.
NextCure, Inc. - Common Stock (NXTC) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,265,273 shares
of 28,027,744 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,711,013 shares), Sofinnova Investments, Inc. (2,671,856 shares), MILLENNIUM MANAGEMENT LLC (1,454,020 shares), BlackRock Inc. (924,423 shares), VANGUARD GROUP INC (908,473 shares), Long Focus Capital Management, LLC (556,105 shares), ACADIAN ASSET MANAGEMENT LLC (488,440 shares), CITADEL ADVISORS LLC (479,847 shares), TANG CAPITAL MANAGEMENT LLC (400,000 shares), and FEDERATED HERMES, INC. (388,569 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.